Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Sep 1995, 604-608, Vol 2, No. 5
WS Sheng, S Hu, FH Kravitz, PK Peterson and CC Chao
Interleukin (IL)-10 appears to play an important regulatory role in the
systemic inflammatory response; however, production of IL-10 within the
human central nervous system has not been described. Using cultures of
human fetal microglial cells, the resident macrophages of the brain, we
investigated the production and regulation of bioactive IL-10.
Lipopolysaccharide stimulated acute release of tumor necrosis factor
(TNF)-alpha (peak by 8 h) and delayed production of IL-10 (over a 48-h
period) in microglial cell cultures. Treatment of microglial cell cultures
with TNF-alpha and IL-6 resulted in a dose-dependent release of IL-10.
These cytokines also induced expression of IL-10 mRNA. Treatment of
microglial cell cultures with IL-10 markedly inhibited TNF- alpha and IL-6
production. These findings suggest that during inflammation within the
brain, acute release of TNF-alpha and IL-6 by activated microglia could
promote subsequent release of IL-10, which functions to minimize the
potential neurotoxic effects of proinflammatory cytokines.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro
Neuroimmunobiology and Host Defense Laboratory, Minneapolis Medical Research Foundation, Minnesota 55404, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |